Trials / Active Not Recruiting
Active Not RecruitingNCT06495229
Study of CM310 in Adolescent Subjects With Atopic Dermatis
A Multicenter, Single Arm, Open Label Study to Evaluate the Safety and Efficacy of CM310 in Adolescent Patients With Atopic Dermatitis
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Keymed Biosciences Co.Ltd · Industry
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, single arm, open label phase 3 study to evaluate the safety and efficacy of CM310 in children patients with moderate-to-severe atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CM310 | Interleukin-4 receptor(IL-4Rα) monoclonal antibody |
Timeline
- Start date
- 2024-08-02
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
- First posted
- 2024-07-10
- Last updated
- 2025-10-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06495229. Inclusion in this directory is not an endorsement.